Indivior (NASDAQ:INDV) Sees Strong Trading Volume

Indivior PLC (NASDAQ:INDV) shares saw unusually-high trading volume on Monday . Approximately 267,165 shares were traded during mid-day trading, an increase of 15% from the previous session’s volume of 232,865 shares.The stock last traded at $12.71 and had previously closed at $12.79.

Wall Street Analysts Forecast Growth

INDV has been the subject of several analyst reports. Craig Hallum cut their target price on shares of Indivior from $37.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Piper Sandler initiated coverage on shares of Indivior in a research note on Tuesday, July 23rd. They issued an “overweight” rating and a $22.00 target price for the company.

Indivior Stock Up 2.0 %

The company has a debt-to-equity ratio of 23.50, a quick ratio of 0.68 and a current ratio of 0.85. The company has a market cap of $1.80 billion, a PE ratio of 1,279.00 and a beta of 0.69. The firm has a fifty day simple moving average of $15.09 and a 200 day simple moving average of $17.66.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.01). The business had revenue of $284.00 million during the quarter, compared to analysts’ expectations of $300.00 million. Indivior had a negative net margin of 12.29% and a negative return on equity of 654.82%. Equities research analysts predict that Indivior PLC will post 1.8 EPS for the current year.

Institutional Trading of Indivior

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in shares of Indivior by 1.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,846,354 shares of the company’s stock worth $134,875,000 after purchasing an additional 90,673 shares during the period. Norges Bank purchased a new stake in shares of Indivior during the 4th quarter worth about $36,011,000. UBS Group AG grew its holdings in shares of Indivior by 71.9% during the 4th quarter. UBS Group AG now owns 826,130 shares of the company’s stock worth $12,615,000 after purchasing an additional 345,556 shares during the period. Renaissance Group LLC grew its holdings in shares of Indivior by 6.1% during the 4th quarter. Renaissance Group LLC now owns 103,023 shares of the company’s stock worth $1,573,000 after purchasing an additional 5,896 shares during the period. Finally, Hsbc Holdings PLC purchased a new stake in shares of Indivior during the 4th quarter worth about $649,000. Hedge funds and other institutional investors own 60.33% of the company’s stock.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.